BACKGROUND. Medullary thyroid cancer (MTC) is a rare cancer. There is a relative paucity
of data over the last decade with regard to the prognosis of these patients. Therefore, the …

BACKGROUND The clinical courses of patients with medullary thyroid carcinoma (MTC)
vary, and a number of prognostic factors have been studied, but the significance of some of …

Aims The aims of this study were to assess the long-term results of treatment of medullary
thyroid carcinoma (MTC) and to define prognostic factors. Methods Retrospective analysis of …

BACKGROUND The prognostic significance of the histologic and clinical features of
medullary thyroid cancer (MTC) and their impact on therapy and outcome have been …

BACKGROUND Prognostic factors of sporadic or inherited medullary thyroid carcinoma
(MTC) are still controversial and have been assessed in old and small series. A better …

Objective The clinical course of patients with medullary thyroid carcinoma (MTC) is variable,
even in the subgroup of patients after surgery with curative intent and postoperatively …

Records of 73 patients with medullary thyroid cancer were reviewed to assess prognostic
factors and the role of external beam radiation therapy. Patients were treated between 1954 …

BACKGROUND Because of the rarity of medullary thyroid carcinoma, adequate information
for determination of the prognostic characteristics and clinical course of this disease can be …

BACKGROUND All patients with medullary carcinoma of the thyroid (MCT) diagnosed in
Sweden during 1959 through 1981 were identified. There were 113 males and 134 females …

BACKGROUND: There have been significant improvements in the management of
medullary thyroid cancer (MTC), and consensus treatment guidelines have been …